Sherry Aulin serves as Executive at Xenon Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Sherry Aulin has executed 7 insider transactions totaling $607.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 2, 2022 involved exercising options for 32 shares valued at $240.
Sherry Aulin currently holds 9,032 shares of Xenon Pharmaceuticals Inc. (XENE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sherry Aulin has been a net seller of XENE stock. They have purchased $0 and sold $607.6K worth of shares.
Sherry Aulin's most recent insider trade was on Sep 2, 2022, when they sold 32 shares at $7.49 per share.
Get notified when new Form 4 filings are submitted
| 9,000 |
| $9.44 |
| Discretionary |
| Sep 2, 2022 | XENE | $607.6K | Sale | 15,355 | $39.57 | Discretionary |
| Sep 2, 2022 | XENE | $6.8K | Option Exercise | 813 | $8.40 | Discretionary |
| Sep 2, 2022 | XENE | $130.2K | Payment | 3,293 | $39.53 | Discretionary |
| Sep 2, 2022 | XENE | $30.9K | Option Exercise | 6,511 | $4.75 | Discretionary |
| Sep 2, 2022 | XENE | $7.1K | Option Exercise | 2,292 | $3.10 | Discretionary |